Letters and urgent communications 2020

Date published: 04 September 2020

Last updated: 31 December 2020

Topics:

Advice from the Chief Medical Officer to HSC professionals for 2020

Documents

HSS (MD) 94/2020 – From the Chief Medical Officer Dr Michael McBride, regarding the UK COVID-19 Vaccination Programmes
PDF (1.4 MB)
HSS (MD) 93/2020 - Deployment of the Astrazeneca Covid-19 Vaccine in Northern Ireland and Updated Jcvi Advice on Covid-19 Vaccines
PDF (494 KB)
HSS (MD) 92/2020 - New Variant of SARS-CoV-2 Virus in South Africa : Action for Health Service in Northern Ireland
PDF (184 KB)
HSS (MD) 91/2020 - COVID-19 Therapeutic Alert - Therapeutic Anticoagulation (Heparin) in the Management of Severe COVID-19 (SARS-CoV-2) Positive Patients
PDF (459 KB)
HSS (MD) 90/2020 - Guidance on death certification during the Covid-19 pandemic
PDF (424 KB)
HSS (MD) 89/2020 - Hysteroscopy: Pain management and informed consent
PDF (180 KB)
HSS (MD) 88/2020 - The Human Medicines (Coronavirus) (Further Amendments) Regulations 2020
PDF (192 KB)
HSS (MD) 87/2020 - Updated Resuscitation Council UK Guidance on the Management of Anaphylaxis in the Vaccination Setting
PDF (392 KB)
HSS(MD) 86/2020 - Covid-19 therapeutic alert - Azithromycin in the management of Covid-19 (Sars-CoV-2) positive patients
PDF (295 KB)
HSS (MD) 85/2020 - Adrenaline for anaphylaxis kits – A reminder to healthcare professionals
PDF (295 KB)
HSS (MD) 84/2020 - Pfizer BioNtech Covid-Vaccine - Updated guidance on managing allergic reactions
PDF (397 KB)
HSS(MD) 83/2020 - Continuation of Seasonal Flu Programme by Peer Vaccinators
PDF (195 KB)
HSS (MD) 82/2020 - Deployment of the Covid-19 Vaccine in Northern Ireland
PDF (688 KB)
HSS (MD) 81/2020 - Atracurium Besilate Solution for Injection Vials and Ampoules (All Strengths) – Supply Disruption Alert
PDF (459 KB)
HSS (MD) 80/2020 – Winter Vaccines and Research
PDF (260 KB)
HSS (MD) 79/2020 - Confirmed Influenza isolates in Northern Ireland - NICE guidance on use of antivirals now applies
PDF (269 KB)
HSS (MD) 78/2020 - Publication of an Interim Position Statement : Tocilizumab for Patients admitted to ICU with COVID-19 Pneumonia (Adults)
PDF (227 KB)
Interim Position Statement: Tocilizumab for patients admitted to ICU with COVID-19 pneumonia (adults) - 25 November 2020
PDF (200 KB)
HSS (MD) 77/2020 - Expression of Interest to all Registered Health Care Professionals to Become Sessional Vaccinators to Help Implement the Forthcoming COVID-19 Vaccination Programme
PDF (189 KB)
HSS (MD) 76/2020 - Supporting Doctors throughout the Second COVID-19 Wave
PDF (175 KB)
HSS (MD) 75/2020 - Publication of a Revised Interim Clinical Commissioning Policy - Remdesivir for Patients Hospitalised with COVID-19 (Adults and Children aged 12 Years and over
PDF (354 KB)
Interim Clinical Commissioning Policy: Remdesivir for patients hospitalised with COVID-19 (adults and children 12 years and older) Version 2
PDF (349 KB)
HSS(MD) 74 2020 - Immediate Actions in response to Mink-Variant Sars-Cov-2 virus in Denmark
PDF (312 KB)
HSS (MD) 73/2020 - Interim Policy to Extend the Provision of Passive Immunisation against Respiratory Syncytial Virus for at Risk Preterm Infants
PDF (253 KB)
HSS (MD) 72/2020 - The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020: Amendments to the Human Medicines Regulations 2012
PDF (482 KB)
HSS (MD) 71/2020 - Lithium Carbonate (Priadel®) 200mg And 400mg Modified Release Tablets – Updated Supply Disruption Alert
PDF (904 KB)
HSS (MD) 70/2020 - COVID-19 - 'Shielding' Guidance for Children and Young People: Royal College of Paediatrics And Child Health (RCPCH)
PDF (503 KB)
HSS (MD) 69/2020 - Remdesivir for patients hospitalised with Covid-19 - Supply disruption alert
PDF (312 KB)
HSS (MD) 68/2020 - Letter to all Health and Social Care workers encouraging everyone to obtain the flu vaccine
PDF (318 KB)
HSS (MD) 67/2020 - Minimising the risk of COVID-19 outbreaks in healthcare settings.
PDF (198 KB)
HSS(MD) 66/2020 - Management of seasonal flu
PDF (764 KB)
HSS (MD) 65/2020 - COVID-19 - Therapeutic alert update : Remdesivir for patients hospitalised with Covid-19 (Adults abd children aged 12 years and older)
PDF (265 KB)
HSS (MD) 64/2020 – COVID-19 Therapeutic Alert Update: Corticosteroids in the Treatment of Suspected or Confirmed COVID-19
PDF (614 KB)
HSS (MD) 63/2020 - National Patient Safety Alert - Steroid Emergency Card to Support Early Recognition and Treatment of Adrenal Crisis in Adults
PDF (893 KB)
HSS (MD) 62/2020 - Lithium Carbonate (Priadel®) 200mg and 400mg Modified Release Tablets – Supply Disruption Alert
PDF (1.3 MB)
HSS (MD) 61/2020 - FOR ACTION: Healthcare Safety Investigation Branch National Learning Report - Severe Brain Injury, Early Neonatal Death and Intrapartum Stillbirth associated with Group B Streptococcus Infection - July 2020
PDF (188 KB)
HSS (MD) 60/2020 - COVID 19 Research letter
PDF (239 KB)
HSS (MD) 59/2020 - Seasonal Influenza Vaccination Programme 2020/21
PDF (1 MB)
HSS (MD) 59/2020 (Addendum) - Seasonal Influenza Vaccination Programme
PDF (656 KB)
HSS (MD) 58/2020 - Use of Face Masks/Face Covering in all Health and Social Care Facilities - Updated as of 11 August 2020
PDF (441 KB)
HSS (MD) 57/2020 - Emollients - New information about risk of severe and fatal burns with paraffin-containing and paraffin-free emollients
PDF (389 KB)
HSS (MD) 56/2020 - National Patient Safety Alert - Risk of Death from Unintended Administration of Sodium Nitrite
PDF (680 KB)
HSS (MD) 55/2020 - Shingles Vaccination Programme Eligibility Criteria for 2020/21
PDF (320 KB)
HSS (MD) 54/2020 - Personal Protective Equipment and Heat - Risk of Heat Stress
PDF (238 KB)
HSS (MD) 53/2020 - Evidence of Harm from Illicit or Fake Benzodiazepines
PDF (486 KB)
HSS (MD) 52/2020 - Cannabis Oil Disguised as Confectionary
PDF (259 KB)
HSS (MD) 51/2020 - Cannabis-based medicinal products - Update
PDF (202 KB)
HSS (MD) 50/2020 - Early Access to Medicines Scheme (EAMS)
PDF (323 KB)
HSS (MD) 49/2020 - COVID-19 Therapeutic Alert Update : Remdesivir for Patients Hospitalised with COVID-19 (Adults and Children aged 12 Years and older
PDF (357 KB)
HSS (MD) 48/2020 - Phenelzine Sulphate 15mg Tablets (Nardil®) – Supply Disruption
PDF (440 KB)
HSS (MD) 47/2020 - Dexamethasone in Covid-19
PDF (179 KB)
HSS (MD) 46/2020 - Re-Scheduling Of Epidyolex (Cannabis Based Medicine) and Insertion of a New Definition under the Misuse Of Drugs Regulations (NI) 2002
PDF (172 KB)
HSS (MD) 45/2020 - Cardiopulmonary Resuscitation (CPR), As An Aerosol Generating Procedure (AGP)
PDF (380 KB)
HSS (MD) 44/2020 - Regional Ethics Advice and Support Framework
PDF (180 KB)
COVID-19 - Guidance Ethical Advice and Support Framework
PDF (1.4 MB)
COVID-19 Guidance - Ethical Advice and Support Framework - Plain English
PDF (193 KB)
COVID-19 Guidance - Ethical Advice and Support Framework - Easy Read
PDF (3 MB)
HSS (MD) 43/2020 - Covid-19 Therapeutic alert further update: Early access to medicines scheme for Rendesivir in the treatment of Covid-19
PDF (299 KB)
HSS (MD) 42/2020 - SARS-CoV2 Antibody Testing - Programme Rollout
PDF (169 KB)
HSS (MD) 41/2020 - COVID-19 Therapeutic Alert Update: Early access to medicines scheme for Remdesivir in the treatment of COVID-19 - Implementation of the scheme and management of supply in Northern Ireland
PDF (307 KB)
HSS (MD) 40/2020 - Danazol 100mg and 200mg Capsules – Supply Disruption Alert
PDF (509 KB)
HSS (MD) 39/2020 - Zyban® (Bupropion Hydrochloride) 150mg Prolonged Release Tablets - Supply Disruption Alert
PDF (564 KB)
HSS (MD) 38/2020 - COVID-19 Contact Tracing Strategy And Programme in Northern Ireland - ‘Test, Trace And Protect’
PDF (402 KB)
HSS (MD) 37/2020 - COVID-19 Therapeutic Alert: Early Access to Medicines Scheme for Remdesivir in the Treatment of Covid-19 – Implementation of the Scheme and Management of Supply in Northern Ireland
PDF (299 KB)
HSS (MD) 36/2020 - Neuromuscular Blocking Agents: Atracurium, Cisatracurium and Rocuronium – Updated Supply Disruption Alert
PDF (615 KB)
HSS (MD) 35/2020 - COVID-19 Case Definition Change
PDF (163 KB)
HSS (MD) 34/2020 - Salazopyrin® (Sulfasalazine) 500mg Suppositories – Supply Disruption Alert
PDF (545 KB)
HSS (MD) 33/2020 - Phosphate Polyfusor 500ml - Supply Disruption Alert
PDF (733 KB)
HSS (MD) 32/2020 - Yellow Card Reporting Site for Healthcare Products Used in Coronavirus (COVID-19)
PDF (197 KB)
HSS (MD) 31/2020 – Valproate Pregnancy Prevention Programme : Temporary Advice for Management during Covid-19 Pandemic
PDF (222 KB)
HSS (MD) 30/2020 - Multisystem Inflammatory Syndrome in Children Temporally Associated with Covid-19
PDF (199 KB)
HSS (MD) 29/2020 - Ativan® (Lorazepam) 4mgml Solution for Injection – Supply Disruption
PDF (1.2 MB)
CMO letter to Professor Greer, Queen's University Belfast - 24 April 2020
PDF (474 KB)
HSS (MD) 28/2020 - Guidance on Death Certification during the COVID-19 Pandemic
PDF (434 KB)
HSS (MD) 27/2020 - Renal Replacement Therapy in Critical Care Severe Disruption to the supply of kits and fluids to perform continuous vein to vein haemofiltration including haemodiafiltration (CVVH and CVVHD)
PDF (1.7 MB)
HSS (MD) 26/2020 - COVID-19 - PPE Guidance Update
PDF (288 KB)
HSS (MD) 25/2020 - Neuromuscular Blocking Agents Atacurium, Cisatracurium and rocuronium - supply disruption alert
PDF (667 KB)
HSS (MD) 24/2020 - Continuation of Immunisation Programmes During COVID-19 Pandemic
PDF (176 KB)
HSS (MD) 23/2020 - COVID-19 – Message to all Clinical Staff – Ibuprofen and Coronavirus (Covid-19)
PDF (561 KB)
HSS (MD) 22/2020 - End of the 2019 2020 Flu Season and Related Issues
PDF (234 KB)
HSS (MD) 21/2020 - COVID 19 - Optimising Use of Critical Care Medicines
PDF (66 KB)
HSS (MD) 20/2020 - COVID-19 - PPE Guidance Update
PDF (350 KB)
HSS (MD) 19/2020 - Personal Protective Equipment (PPE) – Update to Service
PDF (363 KB)
HSS (MD) 18/2020 - Guidance on the New Arrangements for the Completion and Issuing of Medical Certificates of Cause of Death and Stillbirth Certificates
PDF (416 KB)
HSS (MD) 17/2020 - COVID-19 - Chloroquine and Hydroxychloroquine not licensed for COVID-19 treatment
PDF (249 KB)
HSS (MD) 16/2020 - Diamorphine Hydrochloride Powder for reconstitution and injection 5mg and 10mg ampoules - updated supply disruption alert
PDF (920 KB)
HSS (MD) 15/2020 - Novel Coronavirus - Anti-Inflammatory Medications
PDF (173 KB)
HSS (MD) 14/2020 16 March 2020 - Novel Coronavirus: Advice for HSC in Northern Ireland
PDF (162 KB)
HSS(MD) 11 2020 - Epanutin (Phenytoin) 30mg-5ml Oral Suspension - Supply Disruption Alert
PDF (778 KB)
HSS (MD) 13-2020 - COVID-19 Maintaining the supply of medicines to patients
PDF (275 KB)
HSS(MD) 12/2020 - Message for Clinical Staff Encountering Patients with Respiratory Infections Arrived from Overseas
PDF (358 KB)
HSS(MD) 10/2020 - Diamorphine Hydrochloride Powder for Reconstitution and Injection 5mg and 10mg Ampoules – Supply and Distribution
PDF (631 KB)
HSS(MD) 9/2020 - Covid-19 Becomes a Notifiable Disease in Northern Ireland
PDF (63 KB)
HSS (MD) 8/2020 25 February 2020 - Updated Advice In Relation to the Novel Coronavirus (Covid-19) - Includes Flowcharts
PDF (413 KB)
HSS (MD) 07/2020 07 February 2020 - Updated Advice in Relation to the Novel Coronavirus (2019-nCoV) - Includes Contacts and Flowcharts
PDF (645 KB)
HSS (MD) 06/2020 04 February 2020 - Cannabis Based Products for Medicinal Use – Update
PDF (313 KB)
HSS (MD) 05/2020 31 January 2020 - Updated Advice - Novel Coronavirus (2019-nCoV) - Includes Pathway
PDF (455 KB)
HSS (MD) 04/2020 24 January 2020 - Wuhan Novel Coronavirus - Message for all Clinical Staff Encountering Patients with Respiratory Infections Arrived from Overseas
PDF (458 KB)
HSS (MD) 03/2020 24 January 2020 - Change to the Infant Pneumococcal Conjugate Vaccine (PCV13) Schedule
PDF (393 KB)
HSS (MD) 02/2020 22 January 2020 - Publication of a New Regional Policy for the Administration of Intravenous Fluids to Children Aged from Birth (Term) until their 16th Birthday: Reducing the Risk of Harm due to Hyponatraemia and Competency Framework
PDF (2.5 MB)
HSS (MD) 01/2020 15 January 2020 - Phenytoin Sodium NRIM 100MG Capsules (ACCORD) – Supply Disruption Alert
PDF (573 KB)

Help viewing documents

Back to top